Sequencing of the reannotated LMNB2 gene reveals novel mutations in patients with acquired partial lipodystrophy.
The etiology of acquired partial lipodystrophy (APL, also called "Barraquer-Simons syndrome") is unknown. Genomic DNA mutations affecting the nuclear lamina protein lamin A cause inherited partial lipodystrophy but are not found in patients with APL. Because it also encodes a nuclear lamina protein (lamin B2) and its genomic structure was recently reannotated, we sequenced LMNB2 as a candidate gene in nine white patients with APL. In four patients, we found three new rare mutations in LMNB2: intron 1 -6G-->T, exon 5 c.643G-->A (p.R215Q; in two patients), and exon 8 c.1218G-->A (p.A407T). The combined frequency of these mutations was 0.222 in the patients with APL, compared with 0.0018 in a multiethnic control sample of 1,100 subjects (P = 2.1 x 10-7) and 0.0045 in a sample of 330 white controls (P = 1.2 x 10-5). These novel heterozygous mutations are the first reported for LMNB2, are the first reported among patients with APL, and indicate how sequencing of a reannotated candidate gene can reveal new disease-associated mutations.
Hegele
Robert A
RA
Robarts Research Institute, 406-100 Perth Drive, London, Ontario, Canada N6A 5K8. hegele@robarts.ca
Cao
Henian
H
Liu
Dora M
DM
Costain
Gary A
GA
Charlton-Menys
Valentine
V
Rodger
N Wilson
NW
Durrington
Paul N
PN
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003923:Diabetes Mellitus, Lipoatrophic / Q000235:genetics*; D005260:Female; D006801:Humans; D034921:Lamin Type B / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data; D009154:Mutation; D017422:Sequence Analysis, DNA
D034921:Lamin Type B